Sidley Austin LLP - News & Resources - Publications - Legal and Economic Perspectives Concerning U.S. Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers

Highlights

Sidley Updates

News & Media

Publications

Events

Publications

Legal and Economic Perspectives Concerning U.S. Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers

Pharmacoeconomics
2009

Sidley partner and global coordinator of the firm's Healthcare practice, Paul Kalb, has co-authored an article in Pharmacoeconomics which discusses the legal and economic perspectives concerning U.S. government investigations of alleged off-label promotion by drug manufacturers. Dr. Kalb offers the legal perspective for the article.

View Article